The Molecular Diagnostic and Assay Development Hub is focused on expanding our targeted and agnostic diagnostic capabilities against viral threats with pandemic potential. During the two-year start-up ...

BEAVERTON, OR, UNITED STATES, January 13, 2026 /EINPresswire.com/ -- Sedia Biosciences Corporation, a leading developer ...

Please provide your email address to receive an email when new articles are posted on . Testing requires parvalbumins as well as raw and heated extracts from multiple fish species for the greatest ...

Allogene Therapeutics has announced an expanded collaboration with Foresight Diagnostics to develop a minimal residual disease (MRD) assay as a companion diagnostic tool for identifying patients with ...

Researchers in Edinburgh have developed a rapid stool-based test aiming to improve the diagnosis of inflammatory bowel ...